We speak the investor's language in nine sectors.

Contracted offtake, levelised cost, permitting status, and the pipeline behind the platform. Bankability over story.

Permitting risk, grid-connection queues, optimistic resource assumptions, and project-vs-platform conflation.

Project-level debt, development equity, platform growth equity, and structured construction finance.

Infrastructure funds, energy-transition specialists, strategic utilities, and green-debt providers.

Revenue-stacking logic, merchant exposure, route-to-market, and the durability of contracted cash flows.

Merchant-revenue assumptions, degradation curves, offtake counterparty risk, and EPC delivery certainty.

Asset-backed debt, infrastructure equity, and hybrid structures blending contracted and merchant returns.

Infrastructure and energy-storage funds, pension-backed vehicles, and specialist credit.

Real revenue over token narratives, regulatory posture, custody, and a credible institutional use-case.

Token-vs-equity confusion, regulatory ambiguity, treasury risk, and retail-led positioning.

Equity-first rounds, SAFE+token-warrant hybrids, and structured infrastructure financing.

Digital-asset funds with institutional mandates, fintech crossover investors, and strategics.

Net revenue retention, gross margin, the durability of any AI moat, and efficient growth, not just ARR.

Inflated ARR definitions, churn masked by upsell, model-cost economics, and thin defensibility.

Priced equity rounds, venture debt for runway extension, and revenue-based financing for efficient growth.

Software VCs, applied-AI specialists, growth funds, and strategic platform acquirers.

Unit economics net of risk, licensing, take-rate durability, and the quality of underwriting or fraud controls.

Regulatory licensing gaps, loss-rate optimism, balance-sheet vs platform models, and compliance debt.

Equity plus debt/warehouse facilities for lending books, and structured capital for balance-sheet growth.

Fintech specialist VCs, financial strategics, and debt providers for lending capital.

Verifiable impact alongside commercial returns, scalability of the technology, and policy tailwinds.

Impact greenwashing, capital intensity, first-of-a-kind scale-up risk, and subsidy dependence.

Blended finance, grant-plus-equity, catalytic capital, and structured project funding.

Climate and impact funds, corporate venture arms, and development finance institutions.

Hardware-software margin blend, deployment cycle, recurring-revenue attach, and capital efficiency.

Long sales cycles, working-capital intensity, services-vs-product margins, and concentration risk.

Growth equity, asset and inventory finance, and structured capital for working-capital needs.

Industrial-tech VCs, growth funds, strategic OEMs, and specialist asset lenders.

EBITDA quality, capacity utilisation, order-book visibility, and the path from pilot line to scale.

Capex underestimation, yield ramp risk, customer concentration, and supply-chain fragility.

Growth equity, asset-backed and equipment finance, and structured capex facilities.

Industrial growth equity, private equity, strategic acquirers, and asset-based lenders.

Regulatory pathway, clinical evidence, reimbursement strategy, and IP position over headline TAM.

Regulatory-approval timing, reimbursement uncertainty, evidence gaps, and IP defensibility.

Milestone-based equity, non-dilutive grants, venture debt, and strategic partnership capital.

Healthcare and life-science VCs, strategic pharma/medtech, and specialist crossover funds.